rivaroxaban

The medicine is used in adults to prevent blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

This medicine is used in adults to prevent blood clots in the brain (stroke) and other blood vessels (e.g., in atrial fibrillation) and to treat and prevent the recurrence of deep vein thrombosis in the legs and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots in the veins or lungs after initial treatment with injectable medicines.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Betapharm Arzneimittel GmbH

This medicine is used in adults to prevent strokes and other blood clots in the blood vessels (in atrial fibrillation) and to treat and prevent blood clots in the veins of the legs and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Betapharm Arzneimittel GmbH

The medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat deep vein thrombosis and pulmonary embolism, and to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Betapharm Arzneimittel GmbH

The medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (in patients with acute coronary syndrome) and to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Betapharm Arzneimittel GmbH

In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent clots in the veins or lungs after initial injectable treatment.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Stada AG

In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used for the treatment and prevention of blood clots in the veins or lungs.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Stada AG

The medicine is used in adults to treat blood clots in the veins of the legs (deep vein thrombosis) and blood vessels of the lungs (pulmonary embolism), as well as to prevent the recurrence of such clots.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Stada AG

This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent blood clots in the veins or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Chanelle Medical Unlimited Company

This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots in the veins or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Chanelle Medical Unlimited Company

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: ELPEN Pharmaceutical Co. Inc.

This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following a diagnosis of acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: ELPEN Pharmaceutical Co. Inc.

In adults, it is used to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg and lung veins. In children and adolescents (weighing over 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: ELPEN Pharmaceutical Co. Inc.

In adults, the medicine is used to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (over 30 kg), it is used to treat and prevent clots in the veins or lungs after initial treatment with injectable medicines.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: ELPEN Pharmaceutical Co. Inc.

Rivaxar is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (in the case of acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adalvo Ltd. S.C. Labormed-Pharma S.A.

The medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adalvo Ltd. S.C. Labormed-Pharma S.A.

The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation). It is also used to treat deep vein thrombosis in the legs and pulmonary embolism, as well as to prevent the recurrence of these clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adalvo Ltd. S.C. Labormed-Pharma S.A.

The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (e.g., in atrial fibrillation) and to treat and prevent the recurrence of thrombosis in the veins of the legs and in the blood vessels of the lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adalvo Ltd. S.C. Labormed-Pharma S.A.

The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and in the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (over 30 kg), it is used for the treatment and prevention of clots following initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Genepharm S.A.

In adults, it is used to prevent strokes and blood clots (e.g., in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used for the treatment and prevention of blood clots in the veins or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Genepharm S.A.

It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery, and for the treatment of deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Genepharm S.A.

This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adamed Pharma S.A.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adamed Pharma S.A.

The medicine is used in adults to prevent strokes and other blood clots in the case of atrial fibrillation. In adults as well as children and adolescents (over 30 kg), it is used to treat deep vein thrombosis and pulmonary embolism and to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adamed Pharma S.A.

This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the veins of the legs and lungs. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adamed Pharma S.A.

The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent clots in the leg veins and pulmonary vessels. In children and adolescents weighing more than 50 kg, it is used to treat clots after initial treatment with injections.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Adamed Pharma S.A. Pharmadox Healthcare Limited Zentiva S.A.

In adults, it is used to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial treatment with injections.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Adamed Pharma S.A. Pharmadox Healthcare Limited Zentiva S.A.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Adamed Pharma S.A. Pharmadox Healthcare Limited Zentiva S.A.

The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (e.g., in atrial fibrillation) and to treat deep vein thrombosis in the legs and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AX06

Manufacturer: Adamed Pharma S.A.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. It is also used in the treatment of deep vein thrombosis and pulmonary embolism, as well as in preventing the recurrence of clots.

Form: tablets, film-coated

ATC: B01AX06

Manufacturer: Adamed Pharma S.A.

The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (e.g., in atrial fibrillation) and to treat thrombosis in the veins of the legs and pulmonary vessels, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AX06

Manufacturer: Adamed Pharma S.A.

This medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. It is also used to treat blood clots in the veins of the legs and in the blood vessels of the lungs, as well as to prevent them from recurring.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Delorbis Pharmaceuticals Ltd., Lek Pharmaceuticals Ltd., Salutas Pharma GmbH

In adults, the medicine is used to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent clots in the leg and lung veins. In children and adolescents (over 30 kg), it is used to treat clots in the veins or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Delorbis Pharmaceuticals Ltd., Lek Pharmaceuticals Ltd., Salutas Pharma GmbH

In adults, it is used to prevent strokes and blood clots in people with atrial fibrillation, and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (over 30 kg), it is used to treat blood clots in the veins or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Delorbis Pharmaceuticals Ltd., Salutas Pharma GmbH

This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (in patients with acute coronary syndrome) and to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Delorbis Pharmaceuticals Ltd., Lek Pharmaceuticals d.d., Salutas Pharma

The medicine is used in adults to reduce the risk of blood clots. It is prescribed, among other things, in cases of acute coronary syndrome (heart attack or unstable angina) and in patients at high risk of thrombosis due to coronary artery disease or peripheral artery disease.

Form: capsules, hard

ATC: B01AF51

Manufacturer: PharOS Mt Ltd Pharos Pharmaceutical Oriented Services Ltd.

The medicine is used in adults to reduce the risk of another heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: A10BA02

Manufacturer: Actavis Group PTC ehf. Balkanpharma-Dupnitsa AD

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. It is also used to treat deep vein thrombosis and pulmonary embolism, as well as to prevent the recurrence of these clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Actavis Group PTC ehf., Balkanpharma-Dupnitsa AD, Teva Operations Poland Sp. z o.o.

The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins or pulmonary vessels. In children and adolescents (weighing over 30 kg), it is used to treat clots after initial injectable treatment.

Form: tablets, film-coated

ATC: A10BA02

Manufacturer: Actavis Group PTC ehf., Balkanpharma-Dupnitsa AD, Teva Operations Polska Sp. z o.o.

The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent clots in the leg veins or pulmonary vessels. In children and adolescents (weighing over 30 kg), it is used to treat clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Actavis Group PTC ehf., Balkanpharma-Dupnitsa AD, Teva Operations Polska Sp. z o.o.

VIXARGIO is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent recurrent blood clots in the veins or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: McDermott Laboratories Limited (t.a. Gerard Laboratories), Medis International a.s., Mylan Germany GmbH, Mylan Hungary Kft.

VIXARGIO is used in adults to prevent strokes and blood clots (in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: McDermott Laboratories Limited (t.a. Gerard Laboratories), Medis International a.s., Mylan Germany GmbH, Mylan Hungary Kft.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: McDermott Laboratories Limited (t.a. Gerard Laboratories), Medis International a.s., Mylan Germany GmbH, Mylan Hungary Kft.

The medicine is used in adults to treat deep vein thrombosis (in the legs) and pulmonary embolism, as well as to prevent the recurrence of blood clots in the blood vessels of the legs and lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: McDermott Laboratories Limited (t.a. Gerard Laboratories), Medis International a.s., Mylan Germany GmbH, Mylan Hungary Kft.

The medicine is used in adults to reduce the risk of another heart attack or to reduce the risk of death from cardiovascular disease (e.g., after acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: McDermott Laboratories Limited (t.a. Gerard Laboratories), Medis International a.s., Mylan Germany GmbH, Mylan Hungary Kft.

This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome) and to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Lek Pharmaceuticals d.d. PharOS Mt Ltd Rontis Hellas Medical and Pharmaceutical Products S.A.

The medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat deep vein thrombosis and pulmonary embolism, as well as to prevent the recurrence of these clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Lek Pharmaceuticals d.d. PharOS Mt Ltd Rontis Hellas Medical and Pharmaceutical Products S.A.

The medicine is used in adults to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used for the treatment and prevention of venous or pulmonary clots following initial treatment with injections.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Lek Pharmaceuticals d.d. PharOS Mt Ltd Rontis Hellas Medical and Pharmaceutical Products S.A.